key: cord-0883903-o3xunnkq
authors: Zhang, Yuan; Wei, Yanqiu; Yang, Siyuan; Li, Yunlong; Wang, Jing; Nie, Zhaoyan; Bi, Yuhai; Liu, Wenjun; Wang, Linghang; Yang, Limin
title: Rapid and accurate identification of SARS-CoV-2 variants containing E484 mutation
date: 2021-11-10
journal: Innovation (N Y)
DOI: 10.1016/j.xinn.2021.100183
sha: a07d758de038cd3a078b62d7fbb93f4d057cbdd0
doc_id: 883903
cord_uid: o3xunnkq

nan

Early studies have shown that guanine can quench the fluorescence signal of a fluorophore via oxidative electron transfer from guanine, 5 meaning that fluorophores cannot be labelled on guanine nucleotides when designing TaqMan probes. Surprisingly, we found that when guanine paired with cytosine, the fluorophore quenching effect was substantially reduced. Based on this finding, we designed a selfquenching probe with the fluorophore placed adjacent to a guanine nucleotide. Because guanine will automatically quench the fluorescence, the fluorophore produced no signal, i.e., the guanine functioned similarly to the quencher of a TaqMan probe. However, when the probe was hybridized with its complementary sequence, the guanine lost its quenching ability, and the probe generated a fluorescence signal. Importantly, if there was a single base mutation in the complementary sequence that prevented G-C base J o u r n a l P r e -p r o o f pair formation, the probe would not fluoresce due to quenching by the unpaired guanine ( Figure 1A ). This probe can therefore be used for identification of a single nucleotide mutation.

The E484 mutation in the SARS-CoV-2 S protein corresponds to a nucleic acid coding sequence substitution from guanine (in the original Wuhan-Hu-1 isolate, wild type) to adenine (Beta and Gamma VOCs) or cytosine (Kappa former VOI). We designed a self-quenching probe for this site, which emits fluorescence when fully bound to the target sequence in wild-type strains but remains quenched when bound to variants carrying the E484 mutation. We combined this probe with PCR to produce a Beta VOC (GISAID EPI_ISL_1250476) were obtained by in vitro transcription and quantified by digital PCR. We evaluated the analytical sensitivity of the DSQP-qPCR assay using these RNA standards while a TaqMan real-time PCR assay was performed in parallel. The results showed that the limit of detection for the DSQP-qPCR for both the wild type and Beta VOC was as low as 2 copies/reaction, which demonstrated high analytical sensitivity and was consistent with that of the TaqMan PCR assay. Moreover, this assay could effectively distinguish between wild-type and variant viral RNA ( Figure 1D ). We then prepared simulated specimens by spiking different concentrations of inactivated SARS-CoV-2 isolate strain 20SF107 and recombinant lentiviral vector pseudovirus bearing the S gene of the Beta VOC into saliva sampled from healthy individuals. After extracting viral RNA, we used the DSQP-qPCR assay to detect RNA from authentic virus and pseudovirus samples. The results showed that the limit of detection for the virus and pseudovirus reached 200 genome copies/mL, which was consistent with that of the TaqMan PCR assay. We further evaluated the specificity of this assay using a series of respiratory pathogens, including influenza A viruses H1N1 and H3N2, influenza B viruses Yamagata and Victoria, respiratory syncytial virus A/B, parainfluenza virus 1/2/3, adenovirus 3/7, rhinovirus A, and coronaviruses NL63 and HKU1. The results showed that the DSQP-qPCR had no cross-reaction with other viral pathogens and showed good specificity. Unlike TaqMan probe chemistry, this novel probe does not require cleavage by a 5'-exonuclease to release the fluorophore. Theoretically, the DNA polymerase used for DSQP-qPCR is therefore not limited to Taq polymerase. To test this versatility, we tried other DNA polymerases, including modified Taq without 5'-exonuclease, and both Pfu and KOD without 5'-exonuclease but with 3'-exonuclease. The results using the modified Taq were consistent with the results using standard Taq, proving that DSQP-qPCR does not require the assistance of a 5'-exonuclease. However, although Pfu and KOD could also generate Ct values, they could not effectively distinguish single nucleotide mutations like Taq polymerase due to the potential interference of their 3'exonuclease activity. We found that the quenching ability of guanine was weaker than that of the TaqMan probe quencher. The relative fluorescence unit (RFU) change of this self-quenching probe is therefore smaller than that of the TaqMan probe, but the J o u r n a l P r e -p r o o f final result is unaffected. A limitation of DSQP-qPCR is that only guanine or cytosine mutations can be detected by this assay. Nevertheless, the probability of a mutation meeting this requirement exceeds 80%, giving this technique a broad application scope.

Compared with the TaqMan-based assays PCR assays, our technology circumvents the application limitations of traditional real-time PCR to allow accurate identification of single nucleotides, thus expanding the functionality of traditional PCR. Compared to sequencing technology, this method has lower equipment and technical requirements, and is therefore more deployable. Our assay combines the advantages of PCR and sequencing technology; it can not only identify mutant strains as accurately as sequencing technology, but also achieve rapid detection like PCR.

In summary, we have developed a novel DSQP-qPCR technique that enables PCRbased detection of single nucleotide mutations, expanding the potential range of applications for traditional PCR. Using this strategy, we established a rapid nucleic acid detection assay for screening SARS-CoV-2 variants containing the E484 mutation. This assay shows high sensitivity and specificity, and when tested with clinical samples, it showed the same effectiveness in virus detection as TaqMan-based assays. Moreover, the wide availability of standard real-time PCR equipment suggests that the DSQP-qPCR assay can be used as a supplement to viral genome sequencing for first-line 

A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primates

SARS-CoV-2 spike E484K mutation reduces antibody neutralisation

Vaccine Breakthrough Infections with SARS-CoV-2 Variants

Laboratory Diagnosis and Monitoring the Viral Shedding of SARS-CoV-2 Infection. Innovation (N Y). 1, 100061

Fluorescence-quenching phenomenon by photoinduced electron transfer between a fluorescent dye and a nucleotide base

DECLARATION OF INTERESTS The authors declare that they have no conflict of interest